series-a
Stage
2
Investors
About
Biorelate develops AI-based tools to extract and organize biomedical knowledge from literature and data, supporting drug discovery by enabling target identification, validation, and mechanistic understanding.
Explore Biorelate Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.